Geetika Chakravarty, Ph.D.


Intellectual Property

  • PCT Application No. PCT/US2011/048481



Available for

  • Exclusive Licensing
  • Non-exclusive Licensing
  • Scientific Collaboration



Confidential Disclosure Agreement



For more information, please contact:

     Gregory Scott Stein
     Licensing Associate


Biomarker-based Diagnostic to Help Determine Cancer Treatment (printable)

Tulane University is actively seeking commercial entities to further develop and commercialize a novel biomarker-based diagnostic to help determine the aggressiveness of a patient's cancer and the types of treatment that may be most effective.




  • Assessing tumor prolificacy and invasiveness
  • Assessing whether chemotherapy will be part of an effective treatment




  • Predicts prognosis and efficacy of treatment plans
  • Provides oncologists with direction for treatment plan
  • Decreases treatment costs for patients and insurers

Development Status

This technology has been tested extensively in vitro. Laboratory work is ongoing for further data and to understand other predictive capabilities of the biomarker.



Related Publication

Tulane University, New Orleans, LA 70118 504-865-5000